Beskrivelse
Krav
Fullmektig i Norge:
Org.nummer: 982702887
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2011.02.25, US 201161446895 P
2011.06.16, US 201161497650 P
2012.02.06, US 201261595200 P
CHOI I ET AL: "Characterization and comparative genomic analysis of intronless Adams with testicular gene expression", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, vol. 83, no. 4, 1 April 2004 (2004-04-01), pages 636-646, XP004495995, ISSN: 0888-7543, DOI: 10.1016/J.YGENO.2003.10.001 (B1)
VORONINA et al.: "Deletion of Adam6 in Mus musculus leads to male subfertility and deficits in sperm ascent into the oviduct", Biology of Reproduction, vol. 100, no. 3, 28 February 2019 (2019-02-28), pages 686-696, DOI: 10.1093/biolre/ioy210 (B2)
EDWARDS D R ET AL: "The ADAM metalloproteinases", MOLECULAR ASPECTS OF MEDICINE, PERGAMON PRESS, OXFORD, GB, vol. 29, no. 5, 1 October 2009 (2009-10-01), pages 258-289, XP025473840, ISSN: 0098-2997, DOI: 10.1016/J.MAM.2008.08.001 [retrieved on 2008-08-15] (B1)
FEATHERSTONE KAREN ET AL: "The Mouse Immunoglobulin Heavy Chain V-D Intergenic Sequence Contains Insulators That May Regulate Ordered V(D)J Recombination", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 285, no. 13, March 2010 (2010-03), pages 9327-9338, XP002677428, ISSN: 0021-9258 (B1)
HAN CECIL ET AL: "Comprehensive analysis of reproductive ADAMs: relationship of ADAM4 and ADAM6 with an ADAM complex required for fertilization in mice.", BIOLOGY OF REPRODUCTION MAY 2009 LNKD- PUBMED:19129510, vol. 80, no. 5, May 2009 (2009-05), pages 1001-1008, XP002677427, ISSN: 0006-3363 (B1)
LONBERG NILS: "Human antibodies from transgenic animals", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 23, no. 9, 1 September 2005 (2005-09-01), pages 1117-1125, XP002442149, ISSN: 1087-0156, DOI: 10.1038/NBT1135 (B1)
US-A1- 2004 018 626 (B1)
WO-A1-2011/004192 (B1)
WO-A1-2011/158009 (B1)
WO-A1-2013/079953 (B1)
WO-A2-2013/061098 (B1)
"Chapter 10 Knockin Approaches" In: ROEBROEK et al.: "Methods in Molecular Biology. Transgenic mouse methods and protocols", 2003, Humana Press vol. 209, pages 187-200, * (D41 in parent proceedings) * (B2)
"Chapter 8 Gene -Targeting Strategies" In: MELTON et al: "Methods in Molecular Biology, Transgenesis Techniques - Principles and Protocols, 2nd ed", 2002, Humana Press ISBN: 978-0-89603-696-0 pages 151-173, * (D39 in parent proceedings) * (B2)
"Targeted Modification of Mammalian Genomes" In: SORRELL et al.: "Focus on Genome Research", 2004, Nova Biomedical Books page 367, * (D40 in parent proceedings) * (B2)
"Veloclmmune: Immunoglobulin Variable Region Humanized Mice" In: MURPHY et al: "Recombinant Antibodies for Immunotherapy", 2009, Cambridge University Press pages 100-107, * (D42 in parent proceedings) * (B2)
AUSTIN et al.: "The Knockout Mouse Project", NATURE GENETICS, vol. 36, no. 9, 1 September 2004 (2004-09-01), pages 921-924, (B2)
HIROHATA et al.: "Chromosomal Assignment of Two ADAM Genes, TACE (ADAM17) and MLTNB (ADAM19), to Human Chromosomes 2 and 5, Respectively, and ofMltnbto Mouse Chromosome 11", GENOMICS, vol. 54, no. 1, 15 November 1998 (1998-11-15), pages 178-179, (B2)
HOIRUCHI et al: "Chapter 2 STUDIES FROM ADAM KNOCKOUT MICE" In: HOIRUCHI K. et al: "The ADAM Family or Protease", 2005, Springer pages 29-64, (B2)
E-CHIANG LEE ET AL: "Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery", NATURE BIOTECHNOLOGY, vol. 32, no. 4, 16 March 2014 (2014-03-16) , pages 356-363, XP055131583, ISSN: 1087-0156, DOI: 10.1038/nbt.2825 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | Patent endret etter innsigelse i EPO |
EP patent gjort gjeldende i Norge | Venter på oversettelse av endret patent etter innsigelse (B2) i EPO |
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
Korrespondanse (Hovedbrev inn)
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Varsel om betaling av første årsavgift (3319) (PTEP2578688)
|
Utgående
EP Registreringsbrev (3210) (PTEP2578688)
|
Innkommende, AR338995029
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Neste fornyelse/årsavgift:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 14. avg. år (EP) | 2025.01.23 | 5850 | ANAQUA SERVICES | Betalt og godkjent |
Årsavgift 13. avg. år (EP) | 2024.01.25 | 4200 | ANAQUA SERVICES | Betalt og godkjent |
32305338 expand_more expand_less | 2023.05.16 | 5500 | ZACCO NORWAY AS | Betalt |
Opprettholdelse av EP-patent etter innsigelse (B2)
5500 = 1 X 5500
|
||||
Årsavgift 12. avg. år (EP) | 2023.01.20 | 3850 | ANAQUA SERVICES | Betalt og godkjent |
Årsavgift 11. avg. år (EP) | 2022.01.21 | 3500 | ANAQUA SERVICES | Betalt og godkjent |
Årsavgift 10. avg. år (EP) | 2021.01.22 | 3200 | ANAQUA SERVICES | Betalt og godkjent |
Årsavgift 9. avg. år (EP) | 2020.01.27 | 2850 | ANAQUA SERVICES SAS | Betalt og godkjent |
31916993 expand_more expand_less | 2019.11.04 | 5500 | APACE IP AS | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|